Cytotoxic and antioxidant effects of methoxylated stilbene analogues on HepG2 hepatoma and Chang liver cells: Implications for structure activity relationship

被引:31
作者
Hasiah, A. H. [1 ]
Ghazali, A. R. [1 ]
Weber, J. F. F. [2 ]
Velu, S. [2 ]
Thomas, N. F. [3 ]
Hussain, S. H. Inayat [4 ,5 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Allied Hlth Sci, Dept Biomed Sci, Kuala Lumpur 50300, Malaysia
[2] Univ Teknol MARA, Inst Studies Nat Remedies, Puncak Alam, Malaysia
[3] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia
[4] Univ Kebangsaan Malaysia, Environm Hlth Program, Fac Allied Hlth Sci, Kuala Lumpur 50300, Malaysia
[5] Univ Kebangsaan Malaysia, Med Mol Biol Inst, Kuala Lumpur 50300, Malaysia
关键词
cytotoxicity; antioxidant; HepG2 hepatoma cells; Chang liver cells; NF-KAPPA-B; RESVERATROL; CANCER; FLAVONOIDS; PREVENTION; POWER;
D O I
10.1177/0960327110368739
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Stilbenes possess a variety of biological activities including chemopreventive activity. This study was conducted to evaluate the structural activity relationships of six methoxylated stilbene analogues with respect to their cytotoxic effects and antioxidant activities on HepG2 hepatoma and Chang liver cells. The cytotoxic and total antioxidant activities of six stilbene analogues were determined by MTT and Ferric Reducing Antioxidant Power (FRAP) assays, respectively. We found that the cis-methoxylated stilbene: (Z)-3,4,4'-trimethoxystilbene was the most potent and selective antiproliferative agent (IC50 89 mu M) in HepG2 cells. For the total antioxidant activity, compounds possessing hydroxyl groups at the 4' position namely (E)-3-methoxy-4'-hydroxystilbene, (E)-3,5-dimethoxy-4'-hydroxystilbene (pterostilbene), (E)-4-methoxy-4'-hydroxystilbene showed the highest antioxidant activity. Structure activity relationship studies of these compounds demonstrated that the cytotoxic effect and antioxidant activities of the tested compounds in this study were structurally dependent.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 21 条
[1]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[2]   Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation [J].
Ashikawa, K ;
Majumdar, S ;
Banerjee, S ;
Bharti, AC ;
Shishodia, S ;
Aggarwal, BB .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6490-6497
[3]   Resveratrol: A review of preclinical studies for human cancer prevention [J].
Athar, Mohammad ;
Back, Jung Ho ;
Tang, Xmwel ;
Kim, Kwang Ho ;
Kopelovich, Levy ;
Bickers, David R. ;
Kim, Arianna L. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) :274-283
[4]  
Aziz MH, 2003, INT J ONCOL, V23, P17
[5]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[6]   Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry [J].
Firuzi, O ;
Lacanna, A ;
Petrucci, R ;
Marrosu, G ;
Saso, L .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 1721 (1-3) :174-184
[7]   Measuring antioxidant potential in corals using the FRAP assay [J].
Griffin, SP ;
Bhagooli, R .
JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY, 2004, 302 (02) :201-211
[8]   Recent advances in the discovery and development of stilbenes and lactones in anticancer therapy [J].
Inayat-Hussain, SH ;
Thomas, NF .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (06) :819-835
[9]   Cancer chemopreventive activity of resveratrol, a natural product derived from grapes [J].
Jang, MS ;
Cai, EN ;
Udeani, GO ;
Slowing, KV ;
Thomas, CF ;
Beecher, CWW ;
Fong, HHS ;
Farnsworth, NR ;
Kinghorn, AD ;
Mehta, RG ;
Moon, RC ;
Pezzuto, JM .
SCIENCE, 1997, 275 (5297) :218-220
[10]   Molecular basis of chemoprevention by resveratrol:: NF-κB and AP-1 as potential targets [J].
Kundu, JK ;
Surh, YJ .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 555 (1-2) :65-80